Vivalis Animal Health

Vivaldis is an India-based companion animal health company focused on the care, cure, and management of pet health. The company markets and manufactures veterinary drugs, food supplements, over-the-counter products, specialized diets, and other pet-health products, with an emphasis on innovative and differentiated formulations. Its portfolio spans therapeutic categories such as oncology, dermatology, parasiticides, kidney care, neurology, pain management, and nutritional diets for companion animals. In March 2023, Sun Pharmaceutical Industries agreed to acquire a 60% stake in Vivaldis Health and Foods Private Limited, making Vivaldis an operating subsidiary while the business continues to trade under the Vivaldis brand. The company appears to be commercially focused rather than a clinical-stage biotech developer, with products already marketed in India and selected international markets.